ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 72 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,860,248 | -47.1% | 307,479 | -32.2% | 0.00% | -50.0% |
| Q2 2023 | $3,517,212 | +6.7% | 453,249 | -21.6% | 0.00% | 0.0% |
| Q1 2023 | $3,296,327 | -7.2% | 578,303 | -4.1% | 0.00% | 0.0% |
| Q4 2022 | $3,550,415 | +107.9% | 602,787 | +12.9% | 0.00% | +100.0% |
| Q3 2022 | $1,708,000 | -24.7% | 533,888 | +5.5% | 0.00% | -33.3% |
| Q2 2022 | $2,267,000 | +73.3% | 505,987 | +106.6% | 0.00% | +200.0% |
| Q1 2022 | $1,308,000 | +445.0% | 244,899 | +2395.9% | 0.00% | – |
| Q1 2021 | $240,000 | – | 9,812 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
| Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
| Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
| EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
| Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
| Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
| Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
| Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
| EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |